首页> 外文期刊>International archives of allergy and immunology >Allergen-induced basophil CD203c expression as a biomarker for rush immunotherapy in patients with Japanese cedar pollinosis.
【24h】

Allergen-induced basophil CD203c expression as a biomarker for rush immunotherapy in patients with Japanese cedar pollinosis.

机译:过敏原诱导的嗜碱性粒细胞CD203c表达作为日本雪松花粉病患者急诊免疫治疗的生物标志物。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Rush immunotherapy (RIT) can confer rapid clinical benefit on patients with allergic rhinitis or asthma. However, biomarkers representing mechanisms for the efficacy of RIT are still to be established. CD203c is a basophil activation marker known to be upregulated by cross-linking of the FcepsilonRIalpha receptor and may serve as a useful marker. OBJECTIVE: We sought to investigate the changes in allergen-induced CD203c expression in patients with Japanese cedar pollen (JCP) pollinosis who received RIT. Methods: Nine patients treated with RIT were enrolled in the study. Whole blood was incubated with various concentrations of JCP extract. CD203c expression on basophils was quantitated by means of flow cytometry. JCP-specific IgG4 levels in sera were measured with ELISA. Basophil histamine release, CAP-RAST to JCP (JCP-IgE) and total IgE were also examined. The biomarkers listed above were evaluated before and sequentially after RIT. Symptom and quality of life scores were obtained during pre- and posttreatment pollen seasons. RESULTS: All patients showed significant improvement in symptom and quality of life scores after RIT. Serum JCP-specific IgG4 titers were significantly elevated at 1 month and remained at high levels 12 months after the treatment. Stimulation with JCP extract induced enhancement of basophil CD203c expression in a concentration-dependent manner except for 2 subjects in whom no increase in CD203c by an anti-IgE antibody was observed (nonresponders). Significant reductions in the responses were observed in 4 subjects after RIT (reduction in CD203c expression, RCE) whereas no changes were seen in 3 subjects (non-RCE). RCE subjects were older than non-RCE counterparts, with mean ages of 20 and 12 years, respectively. No significant changes in JCP-specific IgE and total IgE levels were seen before and after RIT. CONCLUSION: Allergen-induced CD203c expression in basophils may represent, at least in part, the cellular mechanism for the therapeutic responses to RIT for JCP pollinosis. However, further larger-scale studies to confirm the utility of the test are necessary.
机译:背景:急诊免疫疗法(RIT)可为过敏性鼻炎或哮喘患者带来快速的临床收益。然而,代表RIT功效机制的生物标志物仍有待建立。 CD203c是一种嗜碱性粒细胞激活标记,已知会通过FcepsilonRIalpha受体的交联而上调,并且可以用作有用的标记。目的:我们研究了接受RIT治疗的日本雪松花粉(JCP)花粉病患者中变应原诱导的CD203c表达的变化。方法:纳入9名接受RIT治疗的患者。全血与各种浓度的JCP提取物一起孵育。通过流式细胞术定量在嗜碱性粒细胞上的CD203c表达。用ELISA测量血清中JCP特异性IgG4水平。还检查了嗜碱性粒细胞组胺的释放,向JCP的CAP-RAST(JCP-IgE)和总IgE。上面列出的生物标志物在RIT之前和之后进行了评估。在治疗前和治疗后的花粉季节获得症状和生活质量得分。结果:所有患者在RIT后的症状和生活质量得分均显着改善。血清JCP特异性IgG4滴度在治疗后1个月显着升高,并在治疗12个月后保持高水平。用JCP提取物刺激以浓度依赖的方式诱导嗜碱性粒细胞CD203c表达的增强,除了2名受试者中未观察到抗IgE抗体导致CD203c增加(无反应者)。 RIT后4名受试者观察到反应显着降低(CD203c表达降低,RCE),而3名受试者(非RCE)未见变化。 RCE受试者比非RCE​​受试者年龄大,平均年龄分别为20岁和12岁。 RIT前后,JCP特异性IgE和总IgE水平均未见明显变化。结论:变应原诱导的嗜碱性粒细胞CD203c表达可能至少部分代表了对RIT对JCP花粉症的治疗反应的细胞机制。但是,需要进行进一步的大规模研究以确认该测试的实用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号